Navigation Links
The Japanese Cancer Association and Debiopharm Group™ Present Doctors Arakawa and Kurokawa With the 2011 'JCA-Mauvernay Award' for Their Innovative and Outstanding Research in the Field of Cancer
Date:10/5/2011

LAUSANNE, Switzerland, October 5, 2011 /PRNewswire/ --

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics, today presented the 'JCA-Mauvernay Award' to Doctor Hirofumi Arakawa from the National Cancer Center Research Institute in Tokyo, for his basic research on the 'identification and characterization of p53 target genes' and to Doctor Mineo Kurokawa from the University of Tokyo, for his applied research on 'the molecular pathogenesis and therapeutic targets of hematological malignancies'. The ceremony was held during the 70th Annual Meeting of the Japanese Cancer Association (JCA) in Nagoya, Japan. This year the theme was 'Forward Strides for Cancer Research - Grounds for a Confident Future'. Professor Tetsuo Noda, President of the JCA and Dr Rolland-Yves Mauvernay, Founder and President of Debiopharm Group™ presented both scientists with the 2011 Award for their outstanding and innovative research.

Dr Hirofumi Arakawa works in the division of Cancer Biology at the National Cancer Center Research Institute. Since 1999, he has focused on the p53 (protein 53) tumour suppressor, which functions mainly by controlling the expression of a battery of genes involved in life and death of the cell, and which is referred to as "the guardian of the genome". Dr. Arakawa has identified, characterised and reported over 20 p53-regulated target genes.

Recently his group discovered an unusual mechanism for mitochondrial quality control, in which the p53 pathway controls mitochondrial quality by repairing or eliminating unhealthy mitochondria, suggesting that cancer cells might accumulate unhealthy mitochondria due to p53 mutations. Maintenance of healthy mitochondria prevents aging, cancer, and a variety of degenerative diseases, therefore Dr Arakawa's research offers a new approach of cancer and mitochondrial quality control, suggesting that p5
'/>"/>

SOURCE The Debiopharm Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Circassia Acquires North American and Japanese Rights to Dopexamine
2. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
3. Japanese Cancer Association and Debiopharm Honour Japanese Research
4. Australian Authorities (TGA) First to Grant Final Product Approval for Intercells Vaccine to Prevent Japanese Encephalitis
5. GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
6. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
7. Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace
8. Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
9. Intercell to Host Conference Call and Webcast Today on FDA Approval of IXIARO(R) Japanese Encephalitis Vaccine
10. Intercell Announces European Approval of New Vaccine, IXIARO(R), to Prevent Japanese Encephalitis
11. SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... The empty capsules market is experiencing growth ... technological innovations in the empty capsules market. The ... growth of the empty capsules market. , Get ... of Report , The report will enrich both ... to gauge the pulse of the market which ...
(Date:12/19/2014)... -- Decision Resources Group finds that the Asia ... through 2023 as the aging population, increasing adoption of ... all spur procedure volumes. Growth will be particularly rapid ... and India , where rising ... a larger proportion of the population. Other ...
(Date:12/19/2014)... --  ISN has released its third annual U.S. ... publication series. With data aggregated from over eight billion ... its online contractor management platform, ISNetworld, this three-part series ... statistics. The Contractor Performance ... available in two industry specific volumes: Oil & ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 2ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 3
... America,s,pharmaceutical and biotechnology research companies invested a ... development of new life-changing,medicines and vaccines -- an ... analyses by the Pharmaceutical Research and Manufacturers of,America ... the report coincides,with PhRMA,s 50th anniversary, which it ...
... March 24 GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), ... is very pleased to announce the addition of Dr. ... Current President/CEO,and company co-founder Don Hildebrand remains as Chairman ... be heavily involved in company,development, growth and expansion plans ...
... An information technology,revolution is improving cancer ... according to Supportive Oncology Services, Inc. (SOS), ... PROs are self-,assessments that measure any aspect ... the patient without any interpretation by the ...
Cached Biology Technology:R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 3GeoVax Further Strengthens Management Team 2GeoVax Further Strengthens Management Team 3GeoVax Further Strengthens Management Team 4GeoVax Further Strengthens Management Team 5Patient-Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree 2Patient-Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree 3
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ... 2015-2019"  report to their offering. ... advances in technology. With continuous advances in technology, ... the latest standard that meets the needs and ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... researchers at The Scripps Research Institute has developed a ... cells. The Scripps Research scientists initiated the ... journal Nature Methods because the availability of genetically ... development could have important medical consequences. Research has shown ...
... has found that chlorophyll and its derivative chlorophyllin are effective ... produced by a fungus that is a contaminant of grains ... liver cancer and can work in concert with other ... carefully regulated in the United States, but are often found ...
... is increased evidence that the Arctic could face seasonally ice-free ... documented evidence that the Arctic Ocean and Nordic Seas were ... warm period (3.3 to 3 million years ago). This period ... the end of this century, and is used as an ...
Cached Biology News:Scripps research team develops technique to determine ethnic origin of stem cell lines 2Scripps research team develops technique to determine ethnic origin of stem cell lines 3Chlorophylls effective against aflatoxin 2Chlorophylls effective against aflatoxin 3Arctic could face warmer and ice-free conditions 2
... Ph.D. Peptide Display Cloning System facilitates the ... surface of bacteriophage M13 as coat protein ... displayed peptide and its encoding DNA sequence. ... can then be selected by the straightforward ...
... successful cell culture or fermentation is the ... process, and make rapid adjustments in response ... Chemistry Analyzers provide immediate analysis of key ... and fermentation media. BioProfile analyzers are fully ...
... Vtg in plasma from juvenile or male fish ... disrupting chemicals (EDCs) with estrogenic effects in fish. ... test for the estrogenic effects of EDCs in ... a double-antibody immunometric (sandwich) EIA for analyzing Vtg ...
... has over 23 years of experience in ... have made antibodies to large and small ... antigens, and plasmid DNA-encoded antigens. We understand ... so our hybridoma development programs are never ...
Biology Products: